IntegraGen SA (EPA:ALINT)
France · Delayed Price · Currency is EUR 0.1905
+0.0150 (8.55%)
Aug 21, 2026, 4:38 PM CET
IntegraGen Balance Sheet
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Assets
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 1.12 | 1.9 | 1.83 | 2.46 | 4.78 |
Short-Term Investments | - | - | 1.04 | 2.05 | - |
Cash & Short-Term Investments | 1.12 | 1.9 | 2.88 | 4.51 | 4.78 |
Cash Growth | -41.30% | -34.00% | -36.13% | -5.73% | -6.69% |
Accounts Receivable | 1 | 1.67 | 2.96 | 3.22 | 3.36 |
Other Receivables | 0.26 | 1.49 | 1.34 | 0.27 | 0.49 |
Receivables | 1.26 | 3.16 | 4.3 | 3.49 | 3.85 |
Inventory | 0.13 | 0.21 | 0.31 | 0.39 | 0.34 |
Prepaid Expenses | 0.14 | - | 0.19 | 0.16 | - |
Other Current Assets | 0.01 | - | 0 | 0.01 | - |
Total Current Assets | 2.65 | 5.26 | 7.68 | 8.56 | 8.97 |
Property, Plant & Equipment | 0.07 | - | 0.14 | 0.28 | 0.62 |
Long-Term Investments | 0.03 | - | 0.14 | 0.12 | - |
Other Long-Term Assets | 0.05 | 0.25 | 0.03 | 0.08 | 0.01 |
Total Assets | 2.81 | 5.52 | 8 | 9.02 | 9.6 |
Liabilities
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 1.15 | - | 1.32 | 1.61 | 3.55 |
Accrued Expenses | 0.35 | - | 1.6 | 1.61 | - |
Current Portion of Long-Term Debt | - | - | 0.48 | 0.55 | - |
Current Income Taxes Payable | 1.06 | - | - | - | - |
Current Unearned Revenue | - | - | 1.76 | 1.91 | 0.43 |
Other Current Liabilities | 0.24 | 3.1 | 0.03 | 0.03 | 1.48 |
Total Current Liabilities | 2.79 | 3.1 | 5.18 | 5.7 | 5.46 |
Long-Term Debt | 0.3 | 0.64 | 0.64 | 1.12 | 1.95 |
Long-Term Unearned Revenue | 0.61 | - | - | - | - |
Other Long-Term Liabilities | 0 | 0.01 | 0.17 | 0.02 | 0.01 |
Total Liabilities | 3.71 | 3.76 | 5.99 | 6.84 | 7.42 |
Shareholders' Equity
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 3.36 | 1.76 | 3.36 | 3.36 | 2.19 |
Retained Earnings | -4.27 | - | -1.35 | -1.18 | - |
Comprehensive Income & Other | -0 | - | - | - | - |
Shareholders' Equity | -0.91 | 1.76 | 2.01 | 2.18 | 2.19 |
Total Liabilities & Equity | 2.81 | 5.52 | 8 | 9.02 | 9.6 |
Additional Metrics
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 0.3 | 0.64 | 1.12 | 1.67 | 1.95 |
Net Cash (Debt) | 0.81 | 1.26 | 1.75 | 2.83 | 2.83 |
Net Cash Growth | -35.51% | -28.33% | -38.13% | 0.24% | -9.04% |
Net Cash Per Share | 0.12 | - | 0.27 | 0.43 | - |
Filing Date Shares Outstanding | 6.59 | - | 6.61 | 6.63 | - |
Total Common Shares Outstanding | 6.59 | - | 6.61 | 6.63 | - |
Working Capital | -0.14 | 2.16 | 2.5 | 2.86 | 3.52 |
Book Value Per Share | -0.14 | - | 0.30 | 0.33 | - |
Tangible Book Value | -0.91 | 1.76 | 2.01 | 2.18 | 2.19 |
Tangible Book Value Per Share | -0.14 | - | 0.30 | 0.33 | - |
Machinery | 1.18 | - | 1.54 | 1.92 | - |
Construction In Progress | - | - | - | 0 | - |